Imagine for a moment the tale of two friends, Jim and Joe. Jim takes Gleemonex, which makes it feel like it’s 72 degrees in your head all the time. Joe takes a generic form of the drug, which we’ll call walmonex. If the folks who make Gleemonex realize there’s a problem with the drug, they can immediately slap a warning on the product before getting FDA approval, but if the makers of the walmonex discover that same problem, they currently have to wait for the FDA and the brand-name drug makers to review the issue. This loophole is, quite obviously, a bad thing for consumers. So it’s good news that the FDA is now looking to close it. [More]
During Jon’s last trip to Target, he noticed something unusual: a sign in his checkout lane advising customers, “Cashier Is Hearing Impaired.” He found the sign unnecessary and potentially embarrassing for the employee. What do you think? [More]
It’s tempting to invest in markets that are taking off, but the wisest investors find opportunities that have bottomed out or are just getting started. The fastest way to lose your money is to buy when your target is at its high point. [More]
If you’re still on the fence about whether to spend your stimulus check, pay off debt with it, or stock up on ramen noodles, this checklist may help you decide. Some of the tips are pretty unnecessary—”your job duties are marginalized” and “your company plans to move to a smaller building” shouldn’t be hard to decipher. It never hurts to remind yourself about some of the signs of an impending downsize, however.
Common sense will go a long way in protecting you from scammers masquerading as mystery shopping companies, but here’s a list of warning signs just in case you’re feeling especially gullible the next time you come across a mystery shopper ad and think, as you stare across the cubicles at all the assface jerks you work with, “This might be my ticket out of here.”